Recent update on the role of Chinese material Medica and formulations in diabetic retinopathy

Molecules

Volumn 22, Issue 1, 2017, Pages

  More, Sandeep Vasant ^a   Kim, In Su ^a   Choi, Dong Kug ^a  

^a Konkuk University   (South Korea)

Author keywords

Diabetes; Herbal; Medicine; Retinopathy; Traditional

Indexed keywords

HERBACEOUS AGENT; MATERIA MEDICA;

ADULT; ANIMAL; CHEMISTRY; CHINESE MEDICINE; CLASSIFICATION; DIABETIC RETINOPATHY; DISEASE COURSE; DRUG EFFECTS; HUMAN; MEDICINAL PLANT; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PROCEDURES; RETINA;

ADULT; ANIMALS; DIABETIC RETINOPATHY; DISEASE PROGRESSION; DRUGS, CHINESE HERBAL; HUMANS; MATERIA MEDICA; MEDICINE, CHINESE TRADITIONAL; NEOVASCULARIZATION, PATHOLOGIC; PLANTS, MEDICINAL; RETINA;

EID: 85009509080     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22010076     Document Type: Review

References (153)

1. Whiting, D.R.; Guariguata, L.; Weil, C.; Shaw, J. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 2011, 94, 311-321.
2. Chistiakov, D.A. Diabetic retinopathy: Pathogenic mechanisms and current treatments. Diabetes Metab. Syndr. Clin. Res. Rev. 2011, 5, 165-172.
3. Scanlon, P.H. Diabetic retinopathy. Medicine 2010, 38, 656-660.
4. Shin, E.S.; Sorenson, C.M.; Sheibani, N. Diabetes and retinal vascular dysfunction. J. Ophthalmic Vis. Res. 2014, 9, 362.
5. Resnikoff, S.; Pascolini, D.; Etya'ale, D.; Kocur, I.; Pararajasegaram, R.; Pokharel, G.P.; Mariotti, S.P. Global data on visual impairment in the year 2002. Bull. World Health Organ. 2004, 82, 844-851.
6. Control, D.; Group, C.T.R. The effect of intensive treatment of diabetes on the development and progression of long-Term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993, 329, 977-986.
7. Stratton, I.; Kohner, E.; Aldington, S.; Turner, R.; Holman, R.; Manley, S.; Matthews, D. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001, 44, 156-163.
8. Klein, R.; Klein, B.E.;Moss, S.E.; Cruickshanks, K.J. TheWisconsin epidemiologic study of diabetic retinopathy: XIV. Ten-year incidence and progression of diabetic retinopathy. Arch. Ophthalmol. 1994, 112, 1217-1228.
9. Klein, R.; Knudtson, M.D.; Lee, K.E.; Gangnon, R.; Klein, B.E. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII: The twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008, 115, 1859-1868.
10. Aiello, L.P.; Gardner, T.W.; King, G.L.; Blankenship, G.; Cavallerano, J.D.; Ferris, F.L., 3rd; Klein, R. Diabetic retinopathy. Diabetes Care 1998, 21, 143-156.
11. Patel, S.; Chen, H.; Tinkham, N.H.; Zhang, K. Genetic susceptibility of diabetic retinopathy. Curr. Diabetes Rep. 2008, 8, 257-262.
12. Warpeha, K.; Chakravarthy, U. Molecular genetics of microvascular disease in diabetic retinopathy. Eye 2003, 17, 305-311.
13. Durham, J.T.; Herman, I.M. Microvascular modifications in diabetic retinopathy. Curr. Diabetes Rep. 2011, 11, 253-264.
14. Hudson, C. The clinical features and classification of diabetic retinopathy. Ophthalmic Physiol. Opt. 1996, 16, S43-S48.
15. Ola, M.S.; Nawaz, M.I.; Siddiquei, M.M.; Al-Amro, S.; El-Asrar, A.M.A. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J. Diabetes Complicat. 2012, 26, 56-64.
16. Wilkinson, C.; Ferris, F.L.; Klein, R.E.; Lee, P.P.; Agardh, C.D.; Davis, M.; Dills, D.; Kampik, A.; Pararajasegaram, R.; Verdaguer, J.T. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110, 1677-1682.
17. Patel, A.; Group, A.C. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial. Lancet 2007, 370, 829-840.
18. Lang, G. Laser treatment of diabetic retinopathy. Dev. Ophthalmol. 2007, 39, 48-68.
19. Lewis, H. The role of vitrectomy in the treatment of diabetic macular edema. Am. J. Ophthalmol. 2001, 131, 123-125.
20. Li, D.-D.; Chen, J.-H.; Chen, Q.; Li, G.-W.; Chen, J.; Yue, J.-M.; Chen, M.-L.;Wang, X.-P.; Shen, J.-H.; Shen, X. Swietenia mahagony extract shows agonistic activity to PPAR gamma and gives ameliorative effects on diabetic db/db mice. Acta Pharmacol. Sin. 2005, 26, 220-222.
21. Al-Rowais, N.A. Herbal medicine in the treatment of diabetes mellitus. Saudi Med. J. 2002, 23, 1327-1331.
22. Bailey, C.J.; Day, C. Traditional plant medicines as treatments for diabetes. Diabetes Care 1989, 12, 553-564.
23. Dey, L.; Attele, A. Alternative therapies for type 2 Diabetes. Altern. Med. Rev. 2002, 7, 45-58.
24. Head, K. Natural therapies for ocular disorders, part one: Diseases of the retina. Altern. Med. Rev. J. Clin. Ther. 1999, 4, 342-359.
25. Ceylan-Isik, A.F.; Fliethman, R.M.; Wold, L.E.; Ren, J. Herbal and traditional Chinese medicine for the treatment of cardiovascular complications in diabetes mellitus. Curr. Diabetes Rev. 2008, 4, 320-328.
26. World Health Organization. WHO Traditional Medicine Strategy 2014-2023. Available online: http://apps. who.int/iris/handle/10665/92455 (accessed on 15 May 2016).
27. World Health Organization. Legal Status of Traditional Medicine and Complementary/Alternative Medicine: AWorldwide Review. Available online: http://apps.who.int/medicinedocs/en/d/Jh2943e/(accessed on 15 May 2016).
28. Patwardhan, B.; Mashelkar, R.A. Traditional medicine-inspired approaches to drug discovery: Can Ayurveda show the way forward? Drug Discov. Today 2009, 14, 804-811.
29. Hughes, B. 2008 FDA drug approvals. Nat. Rev. Drug Discov. 2009, 8, 93-96.
30. Kong, D.-X.; Li, X.-J.; Zhang, H.-Y. Where is the hope for drug discovery? Let history tell the future. Drug Discov. Today 2009, 14, 115-119.
31. Wang, Z.; Wang, J.; Chan, P. Treating type 2 diabetes mellitus with traditional Chinese and Indian medicinal herbs. Evid.-Based Complement. Altern. Med. 2013, 2013, 70-75.
32. Kim, J.; Kim, C.-S.; Lee, Y.M.; Sohn, E.; Jo, K.; Kim, J.S. Litsea japonica extract inhibits neuronal apoptosis and the accumulation of advanced glycation end products in the diabetic mouse retina. Mol. Med. Rep. 2015, 12, 1075-1081.
33. Shin, J.Y.; Sohn, J.; Park, K.H. Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model. J. Korean Med. Sci. 2013, 28, 608-613.
34. Kumar, B.; Gupta, S.K.; Nag, T.C.; Srivastava, S.; Saxena, R.; Jha, K.A.; Srinivasan, B.P. Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats. Exp. Eye Res. 2014, 125, 193-202.
35. Yu, Z.; Lu, B.; Sheng, Y.; Zhou, L.; Ji, L.; Wang, Z. Andrographolide ameliorates diabetic retinopathy by inhibiting retinal angiogenesis and inflammation. Biochim. Biophys. Acta (BBA) Gen. Subj. 2015, 1850, 824-831.
36. Ding, Y.; Yuan, S.; Liu, X.; Mao, P.; Zhao, C.; Huang, Q.; Zhang, R.; Fang, Y.; Song, Q.; Yuan, D. Protective Effects of Astragaloside IV on db/db Mice with Diabetic Retinopathy. PLoS ONE 2014, 9, e112207.
37. Kim, J.H.; Lee, Y.M.; Ahn, E.M.; Kim, K.W.; Yu, Y.S. Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation. Mol. Vis. 2009, 15, 1868-1875.
38. Gong, C.-Y.; Yu, Z.-Y.; Lu, B.; Yang, L.; Sheng, Y.-C.; Fan, Y.-M.; Ji, L.-L.; Wang, Z.-T. Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism. Vasc. Pharmacol. 2014, 62, 134-142.
39. Lee, S.-Y.; Min, B.-S.; Kim, J.-H.; Lee, J.-K.; Kim, T.-J.; Kim, C.-S.; Kim, Y.-H.; Lee, H.-K. Flavonoids from the leaves of Litsea japonica and their anti-complement activity. Phytother. Res. 2005, 19, 273-276.
40. Min, B.S.; Lee, S.Y.; Kim, J.H.; Kwon, O.K.; Park, B.Y.; An, R.B.; Lee, J.K.; Moon, H.I.; Kim, T.J.; Kim, Y.H. Lactones from the Leaves of Litsea j aponica and Their Anti-complement Activity. J. Nat. Prod. 2003, 66, 1388-1390.
41. Kim, J.; Kim, C.-S.; Lee, I.S.; Lee, Y.M.; Sohn, E.; Jo, K.; Kim, J.H.; Kim, J.S. Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice. Endocrine 2014, 46, 462-469.
42. Howes, M.-J.R.; Perry, N.S.; Houghton, P.J. Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother. Res. 2003, 17.
43. Bhatt, K.; Flora, S. Oral co-Administration of-lipoic acid, quercetin and captopril prevents gallium arsenide toxicity in rats. Environ. Toxicol. Pharmacol. 2009, 28, 140-146.
44. Bronner, C.; Landry, Y. Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions 1985, 16, 147-151.
45. Fiorani, M.; de Sanctis, R.; Menghinello, P.; Cucchiarini, L.; Cellini, B.; Dachà, M. Quercetin prevents glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells. Free Radic. Res. 2009, 34, 639-648.
46. Chen, Y.; Li, X.-X.; Xing, N.-Z.; Cao, X.-G. Quercetin inhibits choroidal and retinal angiogenesis in vitro. Graefe's Arch. Clin. Exp. Ophthalmol. 2007, 246, 373-378.
47. Cao, X.; Liu, M.; Tuo, J.; Shen, D.; Chan, C.-C. The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice. Exp. Eye Res. 2010, 91, 15-25.
48. Kumar, B.; Gupta, S.K.; Nag, T.C.; Srivastava, S.; Saxena, R. Green tea prevents hyperglycemia-induced retinal oxidative stress and inflammation in streptozotocin-induced diabetic rats. Ophthalmic Res. 2012, 47, 103-108.
49. Kumar Gupta, S.; Kumar, B.; Srinivasan, B.; Nag, T.C.; Srivastava, S.; Saxena, R.; Aggarwal, A. Retinoprotective effects of Moringa oleifera via antioxidant, anti-inflammatory, and anti-Angiogenic mechanisms in streptozotocin-induced diabetic rats. J. Ocul. Pharmacol. Ther. 2013, 29, 419-426.
50. Kim, J.; Kim, K.M.; Kim, C.-S.; Sohn, E.; Lee, Y.M.; Jo, K.; Kim, J.S. Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. Free Radic. Biol. Med. 2012, 53, 357-365.
51. Teng, Y.; Cui, H.; Yang, M.; Song, H.; Zhang, Q.; Su, Y.; Zheng, J. Protective effect of puerarin on diabetic retinopathy in rats. Mol. Biol. Rep. 2009, 36, 1129-1133.
52. Hsu, F.-L.; Liu, I.-M.; Kuo, D.-H.; Chen, W.-C.; Su, H.-C.; Cheng, J.-T. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J. Nat. Prod. 2003, 66, 788-792.
53. Liang, X.; Xiao, S.; Lu, G.; Liang, Y.; Bi, X. Puerarin protects rat pancreatic islets fromdamage by hydrogen peroxide. Eur. J. Pharmacol. 2006, 529, 1-7.
54. Kim, J.M.; Lee, Y.M.; Lee, G.Y.; Jang, D.S.; Bae, K.H.; Kim, J.S. Constituents of the roots of Pueraria lobata inhibit formation of advanced glycation end products (AGEs). Arch. Pharm. Res. 2006, 29, 821-825.
55. Liu, W.; Guo, W.; Guo, L.; Gu, Y.; Cai, P.; Xie, N.; Yang, X.; Shu, Y.; Wu, X.; Sun, Y. Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 response. Int. Immunopharmacol. 2014, 20, 337-345.
56. Hao, L.-N.; Wang, M.; Ma, J.-L.; Yang, T. Puerarin decreases apoptosis of retinal pigment epithelial cells in diabetic rats by reducing peroxynitrite level and iNOS expression. Sheng Li Xue Bao 2012, 64, 199-206.
57. Shang, X.; Pan, H.; Li, M.; Miao, X.; Ding, H. Lonicera japonica Thunb.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J. Ethnopharmacol. 2011, 138, 1-21.
58. Lin, L.M.; Zhang, X.G.; Zhu, J.J.; Gao, H.M.; Wang, Z.M.;Wang, W.H. Two new triterpenoid saponins from the flowers and buds of Lonicera japonica. J. Asian Nat. Prod. Res. 2008, 10, 925-929.
59. Dos Santos, M.D.; Almeida, M.C.; Lopes, N.P.; De Souza, G.E.P. Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol. Pharm. Bull. 2006, 29, 2236-2240.
60. Puupponen Pimiä, R.; Nohynek, L.;Meier, C.; Kähkönen, M.; Heinonen, M.; Hopia, A.; Oksman-Caldentey, K.M. Antimicrobial properties of phenolic compounds from berries. J. Appl. Microbiol. 2001, 90, 494-507.
61. Shi, H.; Dong, L.; Bai, Y.; Zhao, J.; Zhang, Y.; Zhang, L. Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats. Eur. J. Pharmacol. 2009, 623, 119-124.
62. Arion, W.J.; Canfield, W.K.; Ramos, F.C.; Schindler, P.W.; Burger, H.-J.; Hemmerle, H.; Schubert, G.; Below, P.; Herling, A.W. Chlorogenic acid and hydroxynitrobenzaldehyde: New inhibitors of hepatic glucose 6-phosphatase. Arch. Biochem. Biophys. 1997, 339, 315-322.
63. Herling, A.W.; Burger, H.-J.; Schubert, G.; Hemmerle, H.; Schaefer, H.-L.; Kramer, W. Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. Eur. J. Pharmacol. 1999, 386, 75-82.
64. De Sotillo, D.V.R.; Hadley, M. Chlorogenic acid modifies plasma and liver concentrations of: Cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J. Nutr. Biochem. 2002, 13, 717-726.
65. Lim, J.C.W.; Chan, T.K.; Ng, D.S.W.; Sagineedu, S.R.; Stanslas, J.; Wong, W.S.F. Andrographolide and its analogues: Versatile bioactive molecules for combating inflammation and cancer. Clin. Exp. Pharmacol. Physiol. 2012, 39, 300-310.
66. Li, J.; Luo, L.; Wang, X.; Liao, B.; Li, G. Inhibition of NF-B expression and allergen-induced airway inflammation in a mouse allergic asthma model by andrographolide. Cell. Mol. Immunol. 2009, 6, 381.
67. Guan, S.; Tee, W.; Ng, D.; Chan, T.; Peh, H.; Ho, W.; Cheng, C.; Mak, J.; Wong, W. Andrographolide protects against cigarette smoke-induced oxidative lung injury via augmentation of Nrf2 activity. Br. J. Pharmacol. 2013, 168, 1707-1718.
68. Zhu, T.; Zhang, W.; Xiao, M.; Chen, H.; Jin, H. Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice. Int. J. Mol. Sci. 2013, 14, 23581-23596.
69. Zhang, W.-J.; Hufnagl, P.; Binder, B.R.;Wojta, J. Anti-inflammatory activity of astragaloside IV is mediated by inhibition of NF-B activation and adhesion molecule expression. Thromb. Haemost. 2003, 90, 904-914.
70. Zheng, Z.; Liu, D.; Song, C.; Cheng, C.; Hu, Z. Studies on chemical constituents and immunological function activity of hairy root of Astragalus membranaceus. Chin. J. Biotechnol. 1997, 14, 93-97.
71. Gui, D.; Guo, Y.; Wang, F.; Liu, W.; Chen, J.; Chen, Y.; Huang, J.; Wang, N. Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo. PLoS ONE 2012, 7, e39824.
72. Liu, H.;Wei, W.; Sun, W.-Y.; Li, X. Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells. J. Ethnopharmacol. 2009, 122, 502-508.
73. Lv, L.; Wu, S.-Y.; Wang, G.-F.; Zhang, J.-J.; Pang, J.-X.; Liu, Z.-Q.; Xu, W.; Wu, S.-G.; Rao, J.-J. Effect of astragaloside IV on hepatic glucose-regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin. Phytother. Res. 2010, 24, 219-224.
74. Motomura, K.; Fujiwara, Y.; Kiyota, N.; Tsurushima, K.; Takeya, M.; Nohara, T.; Nagai, R.; Ikeda, T. Astragalosides isolated from the root of astragalus radix inhibit the formation of advanced glycation end products. J. Agric. Food Chem. 2009, 57, 7666-7672.
75. Yu, J.; Zhang, Y.; Sun, S.; Shen, J.; Qiu, J.; Yin, X.; Yin, H.; Jiang, S. Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Can. J. Physiol. Pharmacol. 2006, 84, 579-587.
76. Chu, Y.; Zhang, L.; Wang, X.-Y.; Guo, J.-H.; Guo, Z.-X.; Ma, X.-H. The effect of Compound Danshen Dripping Pills, a Chinese herb medicine, on the pharmacokinetics and pharmacodynamics of warfarin in rats. J. Ethnopharmacol. 2011, 137, 1457-1461.
77. Yang, P.J.; Li, S.M.; Lv, Y.P.; Huang, Z.Y.; Huang, H. Effect of compound danshen dripping pills on vascular endothelial function in early diabetic retinopathy patients. Chin. J. Exp. Tradit. Med. Formulae 2013, 19, 340-343.
78. Lian, F.; Wu, L.; Tian, J.; Jin, M.; Zhou, S.; Zhao, M.; Wei, L.; Zheng, Y.; Wang, Y.; Zhang, M. The effectiveness and safety of a danshen-containing Chinese herbal medicine for diabetic retinopathy: A randomized, double-blind, placebo-controlled multicenter clinical trial. J. Ethnopharmacol. 2015, 164, 71-77.
79. Ma, G.; Xu, G.; Xu, L.; Wang, Z. Studies on Chemical Constituents of Dendrobium chrysotoxum Lindl. Acta Pharm. Sin. 1994, 29, 766.
80. Ng, T.B.; Liu, J.; Wong, J.H.; Ye, X.; Sze, S.C.W.; Tong, Y.; Zhang, K.Y. Review of research on Dendrobium, a prized folk medicine. Appl. Microbiol. Biotechnol. 2012, 93, 1795-1803.
81. Zhao, Y.; Son, Y.-O.; Kim, S.-S.; Jang, Y.-S.; Lee, J.-C. Antioxidant and anti-hyperglycemic activity of polysaccharide isolated from Dendrobium chrysotoxum Lindl. BMB Rep. 2007, 40, 670-677.
82. Yu, Z.; Gong, C.; Lu, B.; Yang, L.; Sheng, Y.; Ji, L.; Wang, Z. Dendrobium chrysotoxum Lindl. alleviates diabetic retinopathy by preventing retinal inflammation and tight junction protein decrease. J. Diabetes Res. 2015, 2015.
83. Takikawa, M.; Inoue, S.; Horio, F.; Tsuda, T. Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-Activated protein kinase in diabetic mice. J. Nutr. 2010, 140, 527-533.
84. Wu, X.; Beecher, G.R.; Holden, J.M.; Haytowitz, D.B.; Gebhardt, S.E.; Prior, R.L. Concentrations of Anthocyanins in Common Foods in the United States and Estimation of Normal Consumption. J. Agric. Food Chem. 2006, 54, 4069-4075.
85. Seeram, N.P. Berry fruits: Compositional elements, biochemical activities, and the impact of their intake on human health, performance, and disease. J. Agric. Food Chem. 2008, 56, 627-629.
86. Nakajima, J.-I.; Tanaka, I.; Seo, S.; Yamazaki, M.; Saito, K. LC/PDA/ESI-MS profiling and radical scavenging activity of anthocyanins in various berries. BioMed Res. Int. 2004, 2004, 241-247.
87. Colantuoni, A.; Bertuglia, S.; Magistretti, M.; Donato, L. Effects of Vaccinium Myrtillus anthocyanosides on arterial vasomotion. Arzneim.-Forsch. 1991, 41, 905-909.
88. Lietti, A.; Cristoni, A.; Picci, M. Studies on Vaccinium myrtillus anthocyanosides. I. Vasoprotective and antiinflammatory activity. Arzneim.-Forsch. 1975, 26, 829-832.
89. Matsunaga, N.; Chikaraishi, Y.; Shimazawa, M.; Yokota, S.; Hara, H. Vaccinium myrtillus (Bilberry) extracts reduce angiogenesis in vitro and in vivo. Evid.-Based Complement. Altern. Med. 2010, 7, 47-56.
90. Kim, J.; Kim, C.-S.; Lee, Y.M.; Sohn, E.; Jo, K.; Kim, J.S. Vaccinium myrtillus extract prevents or delays the onset of diabetes-Induced blood-retinal barrier breakdown. Int. J. Food Sci. Nutr. 2015, 66, 236-242.
91. Nalawade, S.M.; Sagare, A.P.; Lee, C.Y.; Kao, C.L.; Tsay, H.S. Studies on tissue culture of Chinese medicinal plant resources in Taiwan and their sustainable utilization. Bot. Bull. Acad. Sin. 2003, 44, 79-98.
92. Prakash, R.O.; Rabinarayan, A.; Kumar, M.S. Zingiber zerumbet (L.) Sm., a reservoir plant for therapeutic uses: A review. Int. J. Res. Ayurveda Pharm. 2011, 2, 1-22.
93. Yob, N.; Jofrry, S.M.; Affandi, M.; Teh, L.; Salleh, M.; Zakaria, Z. Zingiber zerumbet (L.) Smith: A review of its ethnomedicinal, chemical, and pharmacological uses. Evid.-Based Complement. Altern. Med. 2011, 2011, 543216.
94. Hong, T.-Y.; Tzeng, T.-F.; Liou, S.-S.; Liu, I.-M. The ethanol extract of Zingiber zerumbet rhizomes mitigates vascular lesions in the diabetic retina. Vasc. Pharmacol. 2016, 76, 18-27.
95. Raghuram, T.; Sharma, R.; Sivakumar, B.; Sahay, B. Effect of fenugreek seeds on intravenous glucose disposition in non-insulin dependent diabetic patients. Phytother. Res. 1994, 8, 83-86.
96. Marzouk, M.; Soliman, A.; Omar, T. Hypoglycemic and antioxidative effects of fenugreek and termis seeds powder in streptozotocin-diabetic rats. Eur. Rev. Med. Pharmacol. Sci. 2013, 17, 559-565.
97. Chaturvedi, U.; Shrivastava, A.; Bhadauria, S.; Saxena, J.K.; Bhatia, G. A mechanism-based pharmacological evaluation of efficacy of trigonella foenum graecum (fenugreek) seeds in regulation of dyslipidemia and oxidative stress in hyperlipidemic rats. J. Cardiovasc. Pharmacol. 2013, 61, 505-512.
98. Sindhu, G.; Ratheesh, M.; Shyni, G.; Nambisan, B.; Helen, A. Anti-inflammatory and antioxidative effects of mucilage of Trigonella foenum graecum (Fenugreek) on adjuvant induced arthritic rats. Int. Immunopharmacol. 2012, 12, 205-211.
99. Middha, S.; Bhattacharjee, B.; Saini, D.; Baliga, M.; Nagaveni, M.; Usha, T. Protective role of Trigonella foenum graceum extract against oxidative stress in hyperglycemic rats. Eur. Rev. Med. Pharmacol. Sci. 2011, 15, 427-435.
100. Kumar, P.; Kale, R.; McLean, P.; Baquer, N. Antidiabetic and neuroprotective effects of Trigonella foenum-graecum seed powder in diabetic rat brain. Prague Med. Rep. 2012, 113, 33-43.
101. Hur, J. Donguibogam; Namsandang: Seoul, Korea, 2007; p. 98.
102. Rosenfarb, A. Healing Your Eyes with Chinese Medicine: Acupuncture, Acupressure Chinese Herbs; North Atlantic Books: Berkeley, CA, USA, 2007.
103. Lim, J.; Kim, J.; Chung, S.; Cho, S.; Oh, M.; Hwang, W. The Antioxidative and Neuroprotective Effect of Guibi-Tang (Guipitang) and Guibi-Tang gamibang (Guipitang jiaweijang) on PC12 cells. J. Orient. Neuropsychiatry 2009, 20, 1-19.
104. Eun, J.; Song, J. Effects of Kwibi-Tang on serum levels of hormone and the non-specific immune response after immobilization stress in mice. Korean J. Orient. Med. Physiol. Pathol. 2004, 18, 172-178.
105. Kim, H.; Choi, J.; Lim, S. The defensive effect of Keuibi-Tang on the gastric mucous membrane of mouse injured by stress and ethanol. J. Orient. Med. 2003, 24, 155-168.
106. Busta, I.; Xie, H.; Kim, M.-S. The use of Gui-Pi-Tang in small animals with immune-mediated blood disorders. Korea Soc. Vet. J. 2009, 26, 181-184.
107. Lee, Y.M.; Lee, Y.-R.; Kim, C.-S.; Jo, K.; Sohn, E.; Kim, J.S.; Kim, J. Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy. Int. J. Mol. Sci. 2015, 16, 29900-29910.
108. So, H.S.; Oh, J.; Chung, Y.T.; Moon, Y.J.; Kim, D.H.; Moon, B.S.; Lee, H.S.; Baek, S.W.; Park, C.; Lim, Y.S.; et al. The water extract of Samultang protects the lipopolysaccharide (LPS)/phorbol 12-myristate 13-Acetate (PMA)-induced damage and nitric oxide production of C6 glial cells via down-regulation of NF-kappaB. Gen. Pharmacol. 2000, 34, 303-310.
109. Xie, M. Modern Study of the Medical Formulae in Traditional Chinese Medicine; Xue Yue Press: Beijing, China, 1997.
110. Lee, Y.M.; Kim, C.-S.; Jo, K.; Sohn, E.J.; Kim, J.S.; Kim, J. Inhibitory effect of Samul-Tang on retinal neovascularization in oxygen-induced retinopathy. BMC Complement. Altern. Med. 2015, 15, 271.
111. Yi, Z.; Dai, X.; Jiu, Y. Modern Study of Medical Formulae in Traditional Chinese Medicine; Beijing Academy Press: Beijing, China, 1997.
112. Seo, C.-S.; Ha, H.; Jung, D.-Y.; Lee, H.Y.; Shin, H.-K. Evaluation of the immune-stimulating activity of Samul-Tang, a traditional Korean herbal medicine, standardized by HPLC-PDA. Korean J. Orient. Med. 2011, 32, 25-34.
113. Kojima, S.; Inaba, K.; Kobayashi, S.; Kimura, M. Inhibitory effects of traditional Chinese medicine Shimotsu-To and its included crude fractions on adjuvant-induced chronic inflammation of mice. Biol. Pharm. Bull. 1996, 19, 47-52.
114. Yby, J.Y.M.; Hye Kyung, H.; Dae Sun, H.; Hyun Kyoo, S. Subacute toxicity study on Samul-Tang in SD rats. Korean J. Orient. Physiol. Pathol. 2008, 22, 137-141.
115. State Medical License Number: Z20030017; China Food Drug Administration: Beijing, China, 2003.
116. Sheng, S.;Wang, Y.; Long, C.; Su, W.; Rong, X. Chinese medicinal formula Fufang Xueshuantong capsule could inhibit the activity of angiotensin converting enzyme. Biotechnol. Biotechnol. Equip. 2014, 28, 322-326.
117. Yuan, Y.Z.; Yuan, F.; Xu, Q.Y.; Yu, J.; Li, L.; Zhang, J.L. Effect of Fufang Xueshuantong Capsule on a rat model of retinal vein occlusion. Chin. J. Integr. Med. 2011, 17, 296-301.
118. Cheng, Y.X. Clinical effect observation of compound xueshuantong capsule in the treatment of diabetic retinopathy. GuideChinaMed 2013, 11, 215-216.
119. Duan, H.; Huang, J.; Li, W.; Tang, M. Protective effects of fufang xueshuantong on diabetic retinopathy in rats. Evid.-Based Complement. Altern. Med. 2013, 2013.
120. Jian, W.; Yu, S.; Tang, M.; Duan, H.; Huang, J. A Combination of the Main Constituents of Fufang Xueshuantong Capsules Shows Protective Effects against Streptozotocin-induced Retinal Lesions in Rats. J. Ethnopharmacol. 2015, 182, 50-56.
121. Qian, W.; Xiong, X.; Fang, Z.; Lu, H.; Wang, Z. Protective effect of tetramethylpyrazine on myocardial ischemia-reperfusion injury. Evid.-Based Complement. Altern. Med. 2014, 2014, 1-9.
122. Tan, Z. Neural protection by naturopathic compounds-An example of tetramethylpyrazine from retina to brain. J. Ocul. Biol. Dis. Inform. 2009, 2, 57-64.
123. Zhang, Z.; Wei, T.; Hou, J.; Li, G.; Yu, S.; Xin, W. Tetramethylpyrazine scavenges superoxide anion and decreases nitric oxide production in human polymorphonuclear leukocytes. Life Sci. 2003, 72, 2465-2472.
124. Kao, T.-K.; Chang, C.-Y.; Ou, Y.-C.; Chen, W.-Y.; Kuan, Y.-H.; Pan, H.-C.; Liao, S.-L.; Li, G.-Z.; Chen, C.-J. Tetramethylpyrazine reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. Exp. Neurol. 2013, 247, 188-201.
125. Ren, Z.; Ma, J.; Zhang, P.; Luo, A.; Zhang, S.; Kong, L.; Qian, C. The effect of ligustrazine on L-Type calcium current, calcium transient and contractility in rabbit ventricular myocytes. J. Ethnopharmacol. 2012, 144, 555-561.
126. Liao, S.-L.; Kao, T.-K.; Chen, W.-Y.; Lin, Y.-S.; Chen, S.-Y.; Raung, S.-L.; Wu, C.-W.; Lu, H.-C.; Chen, C.-J. Tetramethylpyrazine reduces ischemic brain injury in rats. Neurosci. Lett. 2004, 372, 40-45.
127. Gong, X.; Ivanov, V.N.; Davidson, M.M.; Hei, T.K. Tetramethylpyrazine (TMP) protects against sodium arsenite-induced nephrotoxicity by suppressing ROS production, mitochondrial dysfunction, pro-inflammatory signaling pathways and programed cell death. Arch. Toxicol. 2015, 89, 1057-1070.
128. Liang, X.; Zhou, H.; Ding, Y.; Li, J.; Yang, C.; Luo, Y.; Li, S.; Sun, G.; Liao, X.; Min, W. TMP Prevents Retinal Neovascularization and Imparts Neuroprotection in an Oxygen-Induced Retinopathy ModelTMP Blocks Oxygen-Induced Retinopathy. Investig. Ophthalmol. Vis. Sci. 2012, 53, 2157-2169.
129. Ou, Y.; Dong, X.; Liu, X.-Y.; Cheng, X.-C.; Cheng, Y.-N.; Yu, L.-G.; Guo, X.-L. Mechanism of tetramethylpyrazine analogue CXC195 inhibition of hydrogen peroxide-induced apoptosis in human endothelial cells. Biol. Pharm. Bull. 2010, 33, 432-438.
130. Hosoya, K.-I.; Tomi, M.; Ohtsuki, S.; Takanaga, H.; Ueda, M.; Yanai, N.; Obinata, M.; Terasaki, T. Conditionally immortalized retinal capillary endothelial cell lines (TR-iBRB) expressing differentiated endothelial cell functions derived from a transgenic rat. Exp. Eye Res. 2001, 72, 163-172.
131. Zhu, X.; Wang, K.; Zhang, K.; Tan, X.; Wu, Z.; Sun, S.; Zhou, F.; Zhu, L. Tetramethylpyrazine Protects Retinal Capillary Endothelial Cells (TR-iBRB2) against IL-1-Induced Nitrative/Oxidative Stress. Int. J. Mol. Sci. 2015, 16, 21775-21790.
132. Kogure, T.; Hoshino, A.; Ito, K.; Sato, H.; Tatsumi, T.; Ohyama, Y.; Kawata, E.; Fujita, K.I.; Tamura, J.I. Beneficial effect of complementary alternative medicine on lymphedema with rheumatoid arthritis. Mod. Rheumatol. 2005, 15, 445-449.
133. Shin, I.S.; Yu, Y.B.; Seo, C.S.; Ha, H.K.; Lee, M.Y.; Huang, D.S.; Kim, J.H.; Shin, H.K. Subchronic toxicity of Sipjeondaebo-Tang (SDT) in Sprague-Dawley rats. Regul. Toxicol. Pharmacol. 2011, 59, 375-384.
134. Tagami, K.; Niwa, K.; Lian, Z.; Gao, J.; Mori, H.; Tamaya, T. Preventive effect of Juzen-Taiho-To on endometrial carcinogenesis in mice is based on Shimotsu-To constituent. Biol. Pharm. Bull. 2004, 27, 156-161.
135. Lee, Y.M.; Kim, C.-S.; Sohn, E.; Jo, K.; Lim, H.R.; Kim, S.K.; Kim, J.S.; Kim, J. Sipjeondaebo-Tang, a traditional herbal formula, inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy. Tohoku J. Exp. Med. 2014, 234, 229-236.
136. Altunkaya, A.; Gökmen, V. Effect of various anti-browning agents on phenolic compounds profile of fresh lettuce (L. sativa). Food Chem. 2009, 117, 122-126.
137. Zhang, S.-Y.; Li, B.-Y.; Li, X.-L.; Cheng, M.; Cai, Q.; Yu, F.; Wang, W.-D.; Tan, M.; Yan, G.; Hu, S.-L. Effects of phlorizin on diabetic retinopathy according to isobaric tags for relative and absolute quantification-based proteomics in db/db mice. Mol. Vis. 2013, 19, 812-821.
138. Bateman, H.R.; Liang, Q.; Fan, D.; Rodriguez, V.; Lessner, S.M. Sparstolonin B inhibits pro-Angiogenic functions and blocks cell cycle progression in endothelial cells. PLoS ONE 2013, 8, e70500.
139. Bucolo, C.; Leggio, G.M.; Drago, F.; Salomone, S. Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Biochem. Pharmacol. 2012, 84, 88-92.
140. Gupta, S.K.; Kumar, B.; Nag, T.C.; Agrawal, S.S.; Agrawal, R.; Agrawal, P.; Saxena, R.; Srivastava, S. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J. Ocul. Pharmacol. Ther. 2011, 27, 123-130.
141. Subramoniam, A. Plants with Anti-Diabetes Mellitus Properties; CRC Press: Boca Raton, FL, USA, 2016; pp. 18-432.
142. Ibrahim, A.S.; El-Shishtawy, M.M.; Peña, A.; Liou, G.I. Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol. Vis. 2010, 16, 2033-2042.
143. Yang, L.-P.; Sun, H.-L.; Wu, L.-M.; Guo, X.-J.; Dou, H.-L.; Tso, M.O.; Zhao, L.; Li, S.-M. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 2009, 50, 2319-2327.
144. Shi, X.; Liao, S.; Mi, H.; Guo, C.; Qi, D.; Li, F.; Zhang, C.; Yang, Z. Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Molecules 2012, 17, 12868-12881.
145. Wang, D.-D.; Zhu, H.-Z.; Li, S.-W.; Yang, J.-M.; Xiao, Y.; Kang, Q.-R.; Li, C.-Y.; Zhao, Y.-S.; Zeng, Y.; Li, Y. Crude Saponins of Panax notoginseng Have Neuroprotective Effects to Inhibit Palmitate-Triggered Endoplasmic Reticulum Stress-Associated Apoptosis and Loss of Postsynaptic Proteins in Staurosporine Differentiated RGC-5 Retinal Ganglion Cells. J. Agric. Food Chem. 2016, 64, 1528-1539.
146. Zhao, H.; Shi, X.; Wei, W.; Wang, N. Effect of the regimen of Gaoshan Hongjingtian on the mechanism of poly (ADP-ribose) polymerase regulation of nuclear factor kappa B in the experimental diabetic retinopathy. Chin. Med. J. 2012, 126, 1693-1699.
147. Gao, D.; Guo, Y.; Li, X.; Li, X.; Li, Z.; Xue, M.; Ou, Z.; Liu, M.; Yang, M.; Liu, S. An aqueous extract of Radix Astragali, Angelica sinensis, and Panax notoginseng is effective in preventing diabetic retinopathy. Evid.-Based Complement. Altern. Med. 2013, 2013.
148. Kim, J.; Kim, C.-S.; Sohn, E.; Lee, Y.M.; Jo, K.; Kim, J.S. KIOM-79 protects AGE-induced retinal pericyte apoptosis via inhibition of NF-kappaB activation in vitro and in vivo. PLoS ONE 2012, 7, e43591.
149. Kim, O.S.; Kim, J.; Kim, C.-S.; Kim, N.H.; Kim, J.S. KIOM-79 prevents methyglyoxal-induced retinal pericyte apoptosis in vitro and in vivo. J. Ethnopharmacol. 2010, 129, 285-292.
150. Liu, M.; Pan, Q.; Chen, Y.; Yang, X.; Zhao, B.; Jia, L.; Zhu, Y.; Zhang, B.; Gao, X.; Li, X. Administration of Danhong Injection to diabetic db/db mice inhibits the development of diabetic retinopathy and nephropathy. Sci. Rep. 2015, 5, 11219.
151. Cheng, L.;Meng, X.-B.; Lu, S.;Wang, T.-T.; Liu, Y.; Sun, G.-B.; Sun, X.-B. Evaluation of hypoglycemic efficacy of Tangningtongluo formula, a traditional Chinese Miao medicine, in two rodent animal models. J. Diabetes Res. 2014, 2014.
152. Wang, L.; Wang, N.; Tan, H.-Y.; Zhang, Y.; Feng, Y. Protective effect of a Chinese Medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy. J. Ethnopharmacol. 2015, 169, 295-304.
153. Zhang, F.; Huang, B.; Zhao, Y.; Tang, S.; Xu, H.; Wang, L.; Liang, R.; Yang, H. BNC protects H9c2 cardiomyoblasts from H2O2-induced oxidative injury through ERK1/2 signaling pathway. Evid.-Based Complement. Altern. Med. 2013, 2013.